Trial Profile
Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 12 Apr 2021
Price :
$35
*
At a glance
- Drugs Nimodipine (Primary) ; Nimodipine (Primary) ; Nimodipine (Primary)
- Indications Aneurysm; Subarachnoid haemorrhage
- Focus Adverse reactions
- Sponsors Edge Therapeutics
- 04 Apr 2018 Status changed from recruiting to discontinued.
- 28 Feb 2018 Planned End Date changed from 1 Feb 2018 to 1 Mar 2019.
- 28 Feb 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Mar 2019.